Direkt zum Inhalt
Merck

Diagnosis and treatment of diffuse large B-cell lymphoma in an orangutan (Pongo pygmaeus).

Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians (2015-01-31)
Offiong F Ikpatt, Drury Reavill, Jason Chatfield, Susan Clubb, Joseph D Rosenblatt, Glenn Fonte, Yao-Shan Fan, Carolyn Cray
ZUSAMMENFASSUNG

Lymphoma is a common malignancy observed in companion animals. This type of naturally occurring neoplasia has been uncommonly reported in great apes. Diffuse large B-cell lymphoma was diagnosed in an 8-yr-old captive orangutan (Pongo pygmaeus) with gastrointestinal disease by histologic and immunohistochemical methodologies. The orangutan was treated with three cycles of combination chemotherapy (intravenous Rituxan, cyclophosphamide, doxorubicin, and vincristine). The primate has been in good health and exhibiting normal behaviors for more than 15 mo following treatment.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Doxorubicin -hydrochlorid, 98.0-102.0% (HPLC)
Sigma-Aldrich
Doxorubicin -hydrochlorid, suitable for fluorescence, 98.0-102.0% (HPLC)
USP
Prednison, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Prednison, ≥98%
Doxorubicin -hydrochlorid, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Vincristin -sulfat (Salz), 95.0-105.0% (HPLC), powder or crystals
Supelco
Prednison, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Doxorubicin -hydrochlorid, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Vincristin -sulfat, meets USP testing specifications
Vincristinsulfat, European Pharmacopoeia (EP) Reference Standard